George Decou v. Takeda Pharmaceuticals America, Inc.

SETTLED

Trial
08/27/15 – 10/06/15

Play-button-overlay
Play-button-overlay

Summary

A Nevada state court judge overseeing a potentially $2 billion jury trial over the alleged bladder cancer risks of Takeda Pharmaceutical Co Ltd.’s blockbuster diabetes drug Actos announced Wednesday that the pharmaceutical company and two plaintiffs had tentatively resolved their claims, likely ending a trial that began in August and was expected to continue for weeks.

Click here for more in-depth coverage via the CVN News Blog.

Outcome

Settled

Sessions

AM Session
Openings
3 Chapters
PM Session
Openings
2 Chapters
AUG
27
AM Session
Openings
3 Chapters
AUG
28
AM Session
Not in Session
0 Chapters
SEP
1
AM Session
Plaintiff Witness(es)
2 Chapters
SEP
3
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
7
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
23
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
24
AM Session
Plaintiff Witness(es)
2 Chapters
PM Session
Not in Session
0 Chapters
SEP
25
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
OCT
2
AM Session
Defense Witness(es)
0 Chapters
PM Session
Defense Witness(es)
0 Chapters
OCT
7

Recording Disclaimer: This proceeding was recorded in full.

Suggest a Trial

Suggest a Case

Training Libraries

Training Libraries

Video Library

Video Library

  • Follow Us
  • Contact Us
  • 200 Ashford CTR N
  • Suite 350
  • Dunwoody, GA 30338
  • 877-838-9067

Copyright 2017 Courtroom Connect.